finance and hospira inc. Resources | BNET
On GameSpot: BlizzCon 2008: Diablo III's wizard

BNET Industries

Hospira Inc. (HSP) is in the Pharma Industry

Revenue
Dec 31 2007
$3.4B
Profit
Dec 31 2007
$136.7M
Market Cap
Nov 28 2008
$4.7B

Latest News and Analysis

Additional Resources

  • Yankee Equity Solution Launches $50 Million Fund for Mass.-Based Medtech Companies

    BOSTON -- Yankee Equity Solution YES has launched the $50 million "YES Medical Technology Fund", a private equity vehicle to help Mass.-based medical technology companies with revenues and profits to expand their commercialization efforts. Specifically, the YES Medical Technology Fund will provide growth capital to medtech companies that have revenues...

    Articles 2008-11-21

  • Hospira Names Ken Meyers to Lead Human Resources

    LAKE FOREST, Ill., Nov. 10 /PRNewswire-FirstCall/ -- Hospira, Inc. , a global specialty pharmaceutical and medication delivery company, announced today that Ken Meyers has been named senior vice president, Organizational Transformation and People Development. In this capacity, he will lead the global human resources function with a focus on...

    Articles 2008-11-10

  • Supplier Added to Premier Healthcare Alliance's New Comprehensive IV Therapy Products Portfolio

    CHARLOTTE, N.C. -- Premier Purchasing Partners, LP, today announced that Smiths Medical MD Inc. of St. Paul, Minn., has been added to its new portfolio for IV Therapy Products, becoming the ninth company awarded a contract. Eight companies were announced in August. The portfolio is divided in four...

    Articles 2008-11-07

  • Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments

    - Treatment completed in AlbuferonR Phase 3 trials; first Phase 3 data in December 2008 - - Enrollment completed in LymphoStat-BR Phase 3 trials; first Phase 3 data in mid-2009 - - HGS updates financial guidance - ROCKVILLE, Md., Nov. 6 /PRNewswire-FirstCall/ --...

    Articles 2008-11-06

  • Hospira Reports Third-Quarter 2008 Results

    -- Reaffirms 2008 adjusted* earnings projection -- LAKE FOREST, Ill., Nov. 5 /PRNewswire-FirstCall/ -- Hospira, Inc. , a leading global specialty pharmaceutical and medication delivery company, today reported results for the third quarter of 2008. -- Net sales increased 10.4 percent to $925.5 million during...

    Articles 2008-11-05

  • Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12

    LAKE FOREST, Ill., Nov. 4 /PRNewswire-FirstCall/ -- Hospira, Inc. , a global specialty pharmaceutical and medication delivery company, today announced that Christopher B. Begley, chairman and chief executive officer, and Thomas E. Werner, senior vice president, Finance, and chief financial officer, will make a formal presentation at the 2008...

    Articles 2008-11-04

  • Applied NeuroSolutions Announces Addition of Diagnostic Healthcare Executive Edward Ogunro, Ph.D., to Board of Directors

    VERNON HILLS, Ill. -- Applied NeuroSolutions, Inc. (OTC BB:APNS)(www.appliedneurosolutions.com), a Company focused on the development of an integrated product portfolio for the treatment and diagnosis of Alzheimer's disease AD, today announced the appointment of Edward A. Ogunro, Ph.D., a diagnostic and pharmaceutical industry veteran, to its Board of Directors. ...

    Articles 2008-11-03

  • FDA Approves New Indication for Hospira's Precedex Injection

    - Expands Therapy to Broader Patient Population - LAKE FOREST, Ill., Oct. 30 /PRNewswire-FirstCall/ -- Hospira, Inc. , a global specialty pharmaceutical and medication delivery company, announced today that the U.S. Food and Drug Administration FDA approved a new indication for PrecedexR, the company's innovative drug for...

    Articles 2008-10-30

  • StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists

    MENLO PARK, Calif., Oct. 22 /PRNewswire/ -- StemCor Systems, Inc., a medical device company developing systems for Enabling Regenerative MedicineTM, announced today that it has signed an agreement with Hospira, Inc. to develop and commercialize StemCor's proprietary System for the harvest of bone marrow. (Logo: ...

    Articles 2008-10-22

  • Awards for Supply Management Excellence to Be Presented at Aberdeen Group's Chief Procurement Officer's Summit

    Aberdeen Group, a Harte-Hanks Company (NYSE: HHS), will reveal the winners of its industry achievement awards in globalsupply management at its 4th annual Chief Procurement Officer's CPOSummit on November 13-14, 2008 in San Francisco, CA. Aberdeen will presentfive companies with Global Supply Management Achievement Awards forexcellence demonstrated in 5 specific...

    Articles 2008-10-16

  • Hospira Acquires EndoTool From MD Scientific

    - Innovative glucose control management system helps enhance quality of care and patient safety - LAKE FOREST, Ill., Oct. 13 /PRNewswire-FirstCall/ -- Hospira, Inc. , a global specialty pharmaceutical and medication delivery company, announced today that it has acquired the EndoToolR business from MD Scientific, LLC. The...

    Articles 2008-10-13

  • Circassia Acquires North American and Japanese Rights to Dopexamine

    Circassia Establishes Commercial-Scale Supply Chain Circassia to Develop Dopexamine as Part of Proprietary Post-Surgery Recovery Protocols OXFORD, England, October 8 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on the fields of allergy and critical care, announced today that it has acquired the US,...

    Articles 2008-10-08

  • Hospira Hosts Conference Call for Third-Quarter 2008 Earnings

    LAKE FOREST, Ill., Oct. 7 /PRNewswire-FirstCall/ -- Hospira, Inc. , a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its third-quarter 2008 results on Wednesday, Nov. 5, 2008, at 8 a.m. Central time. The company will...

    Articles 2008-10-07

  • page 1 of 1
  • Incorporated: 2003
  • CEO: Mr. Christopher B. Begley

Hospira is a global specialty pharmaceutical and medication delivery company focusing on products that improve the productivity, safety and efficacy of patient care in the acute care setting. Co. is engaged in the development, manufacture and marketing of specialty injectable pharmaceuticals and medication delivery systems that deliver drugs and intravenous fluids. Co. provides contract manufacturing services to pharmaceutical and biotechnology companies for formulation development, filling and finishing of injectable pharmaceuticals. Co.'s products are used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.

Key Competitors

advertisement
Hospira Inc. Company Info

Board of Directors

Mr. Christopher B. Begley

Chairman

Miss Barbara L. Bowles

Mr. Irving W. Bailey II

Lead Director

Mr. Ronald A. Matricaria

Dr. Jacque J. Sokolov M.D.

Mr. Roger W. Hale

Mr. John C. Staley

Dr. Connie R. Curran Ed.D.

Dr. Mark F. Wheeler M.D.

Contact Information

275 North Field Drive

Lake Forest, IL

http://www.hospira.com

224 212-2000

NAICS Code

Pharmaceutical Preparation Manufacturing: 325412
advertisement